Global Medical Forum Summit: Is the U.S. Subsidizing the Global Pharmaceutical Market? A European Perspective" 12/5/2003
Global Medical Forum, Washington, D.C.
Compared to the United States, other major industrialized nations spend far less for the latest prescription drugs. Data suggests that it is not uncommon for consumers in Western Europe, for example, to spend 50% to 65% of what the American consumer spends for the same medications - often medications that are sold by U.S. companies and even manufactured in the U.S. At the same time, it is clear that governments in those countries have harmed the innovation process.
The summit addresses the following questions:
- What can we learn from other leading Western systems about managing both the cost and use of pharmaceuticals?
- Does the U.S. need to rethink its current laissez-faire policy toward the global pharmaceutical marketplace or not?
- How do other Western systems control their prescription drug costs, both their price and their utilization. What are the true effects of these systems?
Welcome & Introduction
( video )
(
transcript )
Prof. Raphael H. Levey, M.D., chairman, Global Medical Forum Foundation
Mr. Robert Laszewski, chairman North America, Global Medical Forum
Case Studies
( video )
(
transcript )
Prof. Panos Kanavos, London School of Economics
"A Case Study from the European Market"
Interlocutor: Mr. James Roberts, president, Health Actuaries LLC
Mme. Annie Chicoye, founder and CEO, ACE
"How Pharmaceutical Pricing was Changed in France: A Lesson"
Mr. Tobias J. Levey, Global Medical Forum Foundation
Dr. Robert Geursen, fmr. SVP, Corporate Public Policy, Aventis Pharma.
"An Overview of Pharmaceutical Pricing in the European Community & the Effects of Reference Pricing"
Interlocutor: Dr. Paul Ginsburg, Center for Studying Health System Change
Case Solutions
( video )
(
transcript )
Dr. Heinz Redwood, consultant & advisor to Pharmaceutical Industry
"A Mid-Atlantic Approach to Rational Pharmaceutical Pricing"
Interlocutor: Ms. Jane Sarasohn-Kahn, THINK-Health & Affiliate - Institute for the Future
American Reaction Panel
( video )
(
transcript )
Ms. Kathleen Buto, vice president, Health Policy, Johnson & Johnson
Dr. Sharon Levine, The Permanente Medical Group, Kaiser Permanente
Interlocutor: Mr. Lawrence Leisure, managing partner - Health Services Industry, Accenture
Keynote Reaction
( video )
(
transcript )
Dr. Mark McClellan, commissioner, U.S. Food & Drug Administration
Interlocutor: Dr. John McLaughlin, The McLaughlin Group

Sign up for
email alerts and stay informed about upcoming HealthCasts, and the latest health policy issues, news, and events.
Change Your Video Preferences